Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 1
Submit an article Journal homepage
1,340
Views
0
CrossRef citations to date
0
Altmetric
Coronaviruses

Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2

Qian Wanga Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USAORCID Iconhttps://orcid.org/0000-0001-9549-3140View further author information
ORCID Icon,
Andre Yanchen Yeha Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USA;b School of Medicine, National Taiwan University, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0002-5761-528XView further author information
ORCID Icon,
Yicheng Guoa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USAORCID Iconhttps://orcid.org/0000-0001-5357-660XView further author information
ORCID Icon,
Hiroshi Mohria Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USAORCID Iconhttps://orcid.org/0000-0003-3101-7625View further author information
ORCID Icon,
Jian Yua Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USAORCID Iconhttps://orcid.org/0000-0001-8604-4538View further author information
ORCID Icon,
David D. Hoa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USA;c Department of Microbiology and Immunology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;d Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAORCID Iconhttps://orcid.org/0000-0003-1627-149XView further author information
ORCID Icon &
Lihong Liua Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, USA;d Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3128-8513View further author information
ORCID Icon show all
Article: 2210237 | Received 07 Mar 2023, Accepted 30 Apr 2023, Published online: 25 May 2023

References

  • Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727–11734.
  • Liu L, Wang P, Nair MS, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 Aug;584(7821):450–456.
  • Rogers TF, Zhao F, Huang D, et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020 Aug 21;369(6506):956–963.
  • Zeng C, Evans JP, King T, et al. SARS-CoV-2 spreads through cell-to-cell transmission. Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):e2111400119.
  • Zhao M, Su PY, Castro DA, et al. Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2. PLoS Pathog. 2021 Jun;17(6):e1009683.
  • Rajah MM, Bernier A, Buchrieser J, et al. The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation. J Mol Biol. 2022 Mar 30;434(6):167280.
  • Papa G, Mallery DL, Albecka A, et al. Furin cleavage of SARS-CoV-2 spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog. 2021 Jan;17(1):e1009246.
  • Belouzard S, Millet JK, Licitra BN, et al. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012 Jun;4(6):1011–1033.
  • Wang Q, Iketani S, Li Z, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2023 Jan 19;186(2):279–86 e8.
  • Li L, Liao H, Meng Y, et al. Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1. Cell. 2022 Aug 4;185(16):2952–60 e10.
  • Sheward DJ, Pushparaj P, Das H, et al. Structural basis of Omicron neutralization by affinity-matured public antibodies. bioRxiv. 2022.
  • Nutalai R, Zhou D, Tuekprakhon A, et al. Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell. 2022 Jun 9;185(12):2116–31 e18.
  • Wang K, Jia Z, Bao L, et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature. 2022 Mar;603(7903):919–925.
  • Westendorf K, Zentelis S, Wang L, et al. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep. 2022 May 17;39(7):110812.
  • Zost SJ, Gilchuk P, Case JB, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 Aug;584(7821):443–449.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.